Hi, @pete555947 - I see that this medication has been used more commonly in Asia and Eastern Europe, as you were alluding to, and is not approved by the FDA at this time.

The most recent publication I found on Cerebrolysin is by some authors in China, found in the journal Medicine:
- Efficacy, safety, and cost-effectiveness analysis of Cerebrolysin in acute ischemic stroke: A rapid health technology assessment
https://journals.lww.com/md-journal/fulltext/2024/03290/efficacy,_safety,_and_cost_effectiveness_analysis.40.aspx
Another article appeared in 2022 in Journal of Clinical Medicine by some European authors, mostly from Romania:
-Role and Impact of Cerebrolysin for Ischemic Stroke Care
https://www.mdpi.com/2077-0383/11/5/1273
The latter journal article seems to call for high-quality confirmatory trials with a large number of patients and clinical and cost-effectiveness studies.

I'm tagging @madirdee @elle11 @steveschem, who may have some input to share on cerebrolysin from their research for themselves or a loved one, or from discussions with others.

@pete555947 - I saw that you mentioned you'd previously had a stroke. Are you looking into cerebrolysin? If so, what improvements are you wanting to see?